Follow
Benjamin Mullish
Benjamin Mullish
Clinical Lecturer, Imperial College London
Verified email at imperial.ac.uk - Homepage
Title
Cited by
Cited by
Year
The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridium difficile infection and other potential indications: joint British Society of …
BH Mullish, MN Quraishi, JP Segal, VL McCune, M Baxter, GL Marsden, ...
Gut 67 (11), 1920-1941, 2018
2572018
The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridium difficile infection and other potential indications: joint British Society of …
BH Mullish, MN Quraishi, JP Segal, VL McCune, M Baxter, GL Marsden, ...
Journal of Hospital Infection 100 (Supplement 1), S1-S31, 2018
2562018
International consensus conference on stool banking for faecal microbiota transplantation in clinical practice
G Cammarota, G Ianiro, CR Kelly, BH Mullish, JR Allegretti, Z Kassam, ...
Gut 68 (12), 2111-2121, 2019
2422019
The evolution of the use of faecal microbiota transplantation and emerging therapeutic indications
JR Allegretti, BH Mullish, C Kelly, M Fischer
The Lancet 394 (10196), 420-431, 2019
2082019
Microbial bile salt hydrolases mediate the efficacy of faecal microbiota transplant in the treatment of recurrent Clostridioides difficile infection
BH Mullish, JAK McDonald, A Pechlivanis, JR Allegretti, D Kao, GF Barker, ...
Gut 68 (10), 1791-1800, 2019
1442019
Screening of faecal microbiota transplant donors during the COVID-19 outbreak: suggestions for urgent updates from an international expert panel
G Ianiro, BH Mullish, CR Kelly, H Sokol, Z Kassam, SC Ng, M Fischer, ...
The lancet Gastroenterology & hepatology 5 (5), 430-432, 2020
1352020
Optimized sample handling strategy for metabolic profiling of human feces
J Gratton, J Phetcharaburanin, BH Mullish, HRT Williams, M Thursz, ...
Analytical chemistry 88 (9), 4661-4668, 2016
1262016
Effects of fecal microbiota transplantation with oral capsules in obese patients
JR Allegretti, Z Kassam, BH Mullish, A Chiang, M Carrellas, J Hurtado, ...
Clinical Gastroenterology and Hepatology 18 (4), 855-863. e2, 2020
1222020
Fecal microbiota transplantation in patients with primary sclerosing cholangitis: a pilot clinical trial
JR Allegretti, Z Kassam, M Carrellas, BH Mullish, JR Marchesi, ...
Official journal of the American College of Gastroenterology| ACG 114 (7 …, 2019
1192019
Inhibiting growth of Clostridioides difficile by restoring valerate, produced by the intestinal microbiota
JAK McDonald, BH Mullish, A Pechlivanis, Z Liu, J Brignardello, D Kao, ...
Gastroenterology 155 (5), 1495-1507. e15, 2018
1072018
Depression and the use of antidepressants in patients with chronic liver disease or liver transplantation
BH Mullish, MS Kabir, MR Thursz, A Dhar
Alimentary pharmacology & therapeutics 40 (8), 880-892, 2014
922014
Clostridium difficile infection and antibiotic-associated diarrhoea
BH Mullish, HRT Williams
Clinical Medicine 18 (3), 237, 2018
912018
Reorganisation of faecal microbiota transplant services during the COVID-19 pandemic
G Ianiro, BH Mullish, CR Kelly, Z Kassam, EJ Kuijper, SC Ng, TH Iqbal, ...
Gut 69 (9), 1555-1563, 2020
882020
Functional microbiomics: evaluation of gut microbiota-bile acid metabolism interactions in health and disease
BH Mullish, A Pechlivanis, GF Barker, MR Thursz, JR Marchesi, ...
Methods 149, 49-58, 2018
732018
Antibiotic therapy and outcome from immune-checkpoint inhibitors
DJ Pinato, D Gramenitskaya, DM Altmann, RJ Boyton, BH Mullish, ...
Journal for immunotherapy of cancer 7 (1), 1-8, 2019
702019
High-throughput, machine learning–based quantification of steatosis, inflammation, ballooning, and fibrosis in biopsies from patients with nonalcoholic fatty liver disease
R Forlano, BH Mullish, N Giannakeas, JB Maurice, N Angkathunyakul, ...
Clinical Gastroenterology and Hepatology 18 (9), 2081-2090. e9, 2020
642020
Faecal microbiota transplantation for recurrent Clostridioides difficile infection: An updated systematic review and meta-analysis
SMD Baunwall, MM Lee, MK Eriksen, BH Mullish, JR Marchesi, ...
EClinicalMedicine 29, 100642, 2020
612020
Immunotoxicity from checkpoint inhibitor therapy: clinical features and underlying mechanisms
P Fessas, LA Possamai, J Clark, E Daniels, C Gudd, BH Mullish, ...
Immunology 159 (2), 167-177, 2020
612020
Anticoagulation in chronic liver disease
A Dhar, BH Mullish, MR Thursz
Journal of hepatology 66 (6), 1313-1326, 2017
522017
The gut microbiome: an under-recognised contributor to the COVID-19 pandemic?
JP Segal, JWY Mak, BH Mullish, JL Alexander, SC Ng, JR Marchesi
Therapeutic Advances in Gastroenterology 13, 1756284820974914, 2020
502020
The system can't perform the operation now. Try again later.
Articles 1–20